IDXG

Interpace Diagnostics Group, Inc. Common Stock

$1.06 -$0.01 -0.54%



Shares Bought4
Shares Sold4
Total8
Shares Owned0
Last Price$1.06
Total Return$0.15
Range Today$1.06 - $1.10
52 Week Range$0.72 - $4.86
Open$1.09
Market Cap$24.52M
Volume/Average140.41K/1.87M
P/E Ratio0.36
Dividend/Yield-




Interpace Diagnostics Group, Inc. engages in the development and commercialization of molecular diagnostic test. It focuses on early detection high potential progresses to cancer. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-09-25 15:48 17-09-29 17:34 $1.48 $1.50 +$0.02 +1.42% crizisaround michrob
17-09-25 15:41 17-09-29 17:18 $1.47 $1.52 +$0.05 +3.40% crizisaround
17-09-25 15:50 17-09-29 17:32 $1.47 $1.51 +$0.04 +2.72% crizisaround
17-09-25 15:43 17-09-29 17:30 $1.47 $1.51 +$0.04 +2.72% crizisaround